Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Infections Post-Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT02779439
What this trial is testing

Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation

Who this might be right for
CMV InfectionEBVAdenovirus
University of Sydney 25
Testing effectiveness (Phase 2)WithdrawnNCT03982992
What this trial is testing

Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab

Who this might be right for
B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell TransplantationB-Cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia+2 more
Ludwig-Maximilians - University of Munich
Testing effectiveness (Phase 2)Ended earlyNCT04364178
What this trial is testing

Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus
Jessie L. Alexander, MD 8
Not applicableUnknownNCT01139203
What this trial is testing

Prophylaxis of Hepatitis B Virus Recurrence After Liver Transplantation

Who this might be right for
Liver TransplantationHepatitis B
Shanghai Jiao Tong University School of Medicine 300
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Early research (Phase 1)Active Not RecruitingNCT00710892
What this trial is testing

CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin's LymphomaMyelodysplastic Syndrome+1 more
Baylor College of Medicine 10
Early research (Phase 1)Study completedNCT01158274
What this trial is testing

RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell Lymphoma+83 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Looking for participantsNCT06741072
What this trial is testing

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

Who this might be right for
Chronic Kidney Disease, Stage 4Chronic Kidney Disease, Stage 5EBV-Related Lymphoproliferative Disorder+2 more
Ohio State University Comprehensive Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT02580539
What this trial is testing

The Safety and Efficacy of EBV Specific T-cell Lines

Who this might be right for
Epstein-Barr Virus InfectionsPost-Transplant Lymphoproliferative DisorderLymphoma
Dr. Jean-Sebastien Delisle, MD, PhD 12
Not applicableStudy completedNCT03532971
What this trial is testing

Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes

Who this might be right for
BK Virus Infection
Dana-Farber Cancer Institute 100
Early research (Phase 1)WithdrawnNCT02276820
What this trial is testing

Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)

Who this might be right for
Adenovirus Infection
AlloVir
Testing effectiveness (Phase 2)Ended earlyNCT01044745
What this trial is testing

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
University of Nebraska 20
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Not applicableStudy completedNCT04415567
What this trial is testing

Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Jinyang Gu 23
Testing effectiveness (Phase 2)Study completedNCT01427881
What this trial is testing

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more
Fred Hutchinson Cancer Center 43
Not applicableUnknownNCT00886158
What this trial is testing

Virus Surveillance in Pediatric Solid Organ Transplant Recipients

Who this might be right for
Viral Infections
Seattle Children's Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01559844
What this trial is testing

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Who this might be right for
Hepatitis CHepatocellular Carcinoma
Gilead Sciences 61
Not applicableUnknownNCT05556733
What this trial is testing

FMT for Post-acute COVID-19 Syndrome

Who this might be right for
Post-Acute COVID19 SyndromeCOVID-19
Chinese University of Hong Kong 60
Large-scale testing (Phase 3)Looking for participantsNCT04832607
What this trial is testing

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

Who this might be right for
AdV InfectionEBV InfectionCMV Infection+1 more
Tobias Feuchtinger 149
Not applicableStudy completedNCT03300882
What this trial is testing

PREDICT Cytomegalovirus (CMV)

Who this might be right for
Lung Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 84
Next Page